Cargando…
Receptor for advanced glycation end products Glycine 82 Serine polymorphism and risk of cardiovascular events in rheumatoid arthritis
Patients with rheumatoid arthritis (RA) are at risk of excess mortality, predominantly owing to cardiovascular (CV) events. The receptor for advanced glycation end products (RAGE) has been implicated in the perpetuation of the chronic inflammatory response in vascular disease. A Gly82→Ser polymorphi...
Autores principales: | Carroll, Lisa, Frazer, Ian H, Turner, Malcolm, Marwick, Thomas H, Thomas, Ranjeny |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1906817/ https://www.ncbi.nlm.nih.gov/pubmed/17425804 http://dx.doi.org/10.1186/ar2175 |
Ejemplares similares
-
Inflammation predicts accelerated brachial arterial wall changes in patients with recent-onset rheumatoid arthritis
por: Hannawi, Suad, et al.
Publicado: (2009) -
Atherosclerotic disease is increased in recent-onset rheumatoid arthritis: a critical role for inflammation
por: Hannawi, Suad, et al.
Publicado: (2007) -
High avidity autoreactive T cells with a low signalling capacity through the T-cell receptor: central to rheumatoid arthritis pathogenesis?
por: Thomas, Ranjeny, et al.
Publicado: (2008) -
Serum levels of soluble receptor for advanced glycation end products and of S100 proteins are associated with inflammatory, autoantibody, and classical risk markers of joint and vascular damage in rheumatoid arthritis
por: Chen, Yueh-Sheng, et al.
Publicado: (2009) -
Dendritic cells and the promise of antigen-specific therapy in rheumatoid arthritis
por: Thomas, Ranjeny
Publicado: (2013)